Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences?
Publication
, Conference
Le, H; Ryan, K; Wahlstrom, SK; Pendergraft, T; Maculaitis, MC; Will, O; Mulvihill, E; LeBlanc, TW
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
29
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Le, H., Ryan, K., Wahlstrom, S. K., Pendergraft, T., Maculaitis, M. C., Will, O., … LeBlanc, T. W. (2020). Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Le, Hannah, Kellie Ryan, Svea K. Wahlstrom, Trudy Pendergraft, Martine C. Maculaitis, Oliver Will, Emily Mulvihill, and Thomas William LeBlanc. “Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences?” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Le H, Ryan K, Wahlstrom SK, Pendergraft T, Maculaitis MC, Will O, et al. Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Le, Hannah, et al. “Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences?” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 29, 2020.
Le H, Ryan K, Wahlstrom SK, Pendergraft T, Maculaitis MC, Will O, Mulvihill E, LeBlanc TW. Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
29
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences